BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of $247.97 million. The enterprise value is $175.32 million.
Important Dates
The next confirmed earnings date is Wednesday, August 13, 2025, before market open.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 36.90 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 36.90M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +43.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 24.18M |
Valuation Ratios
The trailing PE ratio is 63.31 and the forward PE ratio is 41.01.
| PE Ratio | 63.31 |
| Forward PE | 41.01 |
| PS Ratio | 5.71 |
| Forward PS | 1.09 |
| PB Ratio | 3.89 |
| P/TBV Ratio | 3.89 |
| P/FCF Ratio | 30.93 |
| P/OCF Ratio | 20.44 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 54.13, with an EV/FCF ratio of 21.87.
| EV / Earnings | 44.76 |
| EV / Sales | 4.03 |
| EV / EBITDA | 54.13 |
| EV / EBIT | 93.55 |
| EV / FCF | 21.87 |
Financial Position
The company has a current ratio of 5.03, with a Debt / Equity ratio of 0.09.
| Current Ratio | 5.03 |
| Quick Ratio | 4.66 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.50 |
| Debt / FCF | 0.69 |
| Interest Coverage | 1.33 |
Financial Efficiency
Return on equity (ROE) is 7.41% and return on invested capital (ROIC) is 2.10%.
| Return on Equity (ROE) | 7.41% |
| Return on Assets (ROA) | 1.42% |
| Return on Invested Capital (ROIC) | 2.10% |
| Return on Capital Employed (ROCE) | 2.25% |
| Revenue Per Employee | $362,142 |
| Profits Per Employee | $32,642 |
| Employee Count | 120 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.60 |
Taxes
In the past 12 months, BrainsWay has paid $523,000 in taxes.
| Income Tax | 523,000 |
| Effective Tax Rate | 11.78% |
Stock Price Statistics
The stock price has increased by +85.40% in the last 52 weeks. The beta is 0.33, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +85.40% |
| 50-Day Moving Average | 11.91 |
| 200-Day Moving Average | 10.31 |
| Relative Strength Index (RSI) | 64.43 |
| Average Volume (20 Days) | 55,789 |
Short Selling Information
| Short Interest | 82,203 |
| Short Previous Month | 109,954 |
| Short % of Shares Out | 0.70% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.72 |
Income Statement
In the last 12 months, BrainsWay had revenue of $43.46 million and earned $3.92 million in profits. Earnings per share was $0.08.
| Revenue | 43.46M |
| Gross Profit | 32.38M |
| Operating Income | 1.87M |
| Pretax Income | 778,000 |
| Net Income | 3.92M |
| EBITDA | 3.24M |
| EBIT | 1.87M |
| Earnings Per Share (EPS) | $0.08 |
Full Income StatementBalance Sheet
The company has $71.60 million in cash and $5.57 million in debt, giving a net cash position of $66.04 million or $1.79 per share.
| Cash & Cash Equivalents | 71.60M |
| Total Debt | 5.57M |
| Net Cash | 66.04M |
| Net Cash Per Share | $1.79 |
| Equity (Book Value) | 63.75M |
| Book Value Per Share | 1.73 |
| Working Capital | 67.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $12.13 million and capital expenditures -$4.11 million, giving a free cash flow of $8.02 million.
| Operating Cash Flow | 12.13M |
| Capital Expenditures | -4.11M |
| Free Cash Flow | 8.02M |
| FCF Per Share | $0.22 |
Full Cash Flow StatementMargins
Gross margin is 74.51%, with operating and profit margins of 4.31% and 9.01%.
| Gross Margin | 74.51% |
| Operating Margin | 4.31% |
| Pretax Margin | 10.22% |
| Profit Margin | 9.01% |
| EBITDA Margin | 7.45% |
| EBIT Margin | 4.31% |
| FCF Margin | 18.45% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 1.58% |
| FCF Yield | 3.23% |
Analyst Forecast
The average price target for BrainsWay is $14.25, which is 12.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.25 |
| Price Target Difference | 12.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BrainsWay has an Altman Z-Score of 2.37 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.37 |
| Piotroski F-Score | 6 |